Changquan Ling
- Molecular Biology top 5%
- Cancer Research top 5%
- Pharmacology top 2%
- Complementary and alternative medicine top 0.5%
- Oncology top 10%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (20 papers)Natural product bioactivities and synthesis (14 papers)Cancer Mechanisms and Therapy (14 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Changquan Ling
150 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 158
- Molecular Biology 1.7k
- Cancer Research 584
- Pharmacology 498
- Complementary and alternative medicine 448
- Oncology 402
Countries citing papers authored by Changquan Ling
This map shows the geographic impact of Changquan Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changquan Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changquan Ling more than expected).
Fields of papers citing papers by Changquan Ling
This network shows the impact of papers produced by Changquan Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changquan Ling. The network helps show where Changquan Ling may publish in the future.
Co-authorship network of co-authors of Changquan Ling
This figure shows the co-authorship network connecting the top 25 collaborators of Changquan Ling. A scholar is included among the top collaborators of Changquan Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changquan Ling. Changquan Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 2 | |
| 4 | 10 | |
| 5 | 13 | |
| 6 | 10 | |
| 7 | 12 | |
| 8 | 28 | |
| 9 | 30 | |
| 10 | 13 | |
| 11 | 32 | |
| 12 | 53 | |
| 13 | 5 | |
| 14 | 66 | |
| 15 | 6 | |
| 16 | 82 | |
| 17 | 20 | |
| 18 | 32 | |
| 19 | 20 | |
| 20 | 13 |
About Changquan Ling
Changquan Ling is a scholar working on Complementary and alternative medicine, Hepatology and Pharmacology, having authored 155 papers that have together received 3.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Natural product bioactivities and synthesis (14 papers) and Cancer Mechanisms and Therapy (14 papers). The work is most often cited by research in Complementary and alternative medicine (448 citations), Pharmacology (374 citations) and Hepatology (310 citations). Changquan Ling has collaborated with scholars based in China, United States and India. Frequent co-authors include Binbin Cheng, Juan Du, Chen Ling, Xiaoqiang Yue, Xiaofeng Zhai, Qing-Hui Zhou, Hailiang Xin, Wanfu Lin, Xiaoyan Zhu and Min Li. Their work appears in journals such as Advanced Materials, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.